©The Author(s) 2025.
World J Gastrointest Pharmacol Ther. Dec 5, 2025; 16(4): 110843
Published online Dec 5, 2025. doi: 10.4292/wjgpt.v16.i4.110843
Published online Dec 5, 2025. doi: 10.4292/wjgpt.v16.i4.110843
Table 1 Studies showing therapeutic role of enteric nervous system on functional bowel disorders
| No. | Ref. | Study characteristics | Key role of ENS |
| 1 | Baj et al[54] | Investigates the potential therapeutic use of marine toxins in treating visceral pain associated with gastrointestinal disorders | Focuses on the role of ENS in visceral pain perception and potential modulation via marine toxins |
| 2 | Bosi et al[55] | Examines how hyaluronan regulates neuronal and immune function in the rat small intestine and microbiota following ischemia/reperfusion injury | Highlights the ENS's involvement in gut motility and immune responses, particularly in the context of injury |
| 3 | Chai et al[56] | Studies the role of stem cell growth factor/c-Kit in the pathogenesis of IBS | Focuses on ENS's involvement in the pathophysiology of IBS, particularly in neuroimmune interactions |
| 4 | Chang et al[57] | Investigates how targeting enteric glial CRF-R1/Cx43 attenuates stress-induced accelerated colonic motility | Demonstrates the role of enteric glia and receptors in stress-induced gastrointestinal dysfunction |
| 5 | Chen et al[58] | Explores how patchouli alcohol restores gut homeostasis in IBS with diarrhea through neurotransmitter regulation via myosin Va | ENS plays a key role in restoring intestinal balance and regulating gut motility in IBS through neurotransmission |
| 6 | Cheng[59] | Identifies calcium-sensing receptor as a new therapeutic target for diarrhea | Focuses on how ENS receptors can be targeted to improve gastrointestinal disorders, specifically diarrhea |
| 7 | Del Colle et al[60] | Explores novel aspects of enteric serotonergic signaling in both health and brain-gut diseases | Examines serotonergic signaling in the ENS and its implications for gut function and diseases like IBS |
| 8 | Dong et al[61] | Investigates the role of Na+/Ca2+ exchanger 1 as a mechanosensitive molecule in esophageal myenteric neurons | Highlights the mechanosensitive role of ENS neurons in regulating esophageal motility and responsiveness |
| 9 | Guarino et al[62] | Explores the role of the gastrointestinal neuromuscular apparatus as an underestimated target of gut microbiota | Focuses on the interaction between ENS, microbiota, and neuromuscular function in gastrointestinal health |
| 10 | Gulbransen and Christofi[63] | Investigates the potential of targeting enteric glia in gastrointestinal diseases and motility disorders | Highlights the emerging therapeutic role of enteric glia in modulating motility disorders and disease states |
| 11 | Holland et al[64] | Discusses the regulation of microRNA in enteric nervous system development and its role in disease | Emphasizes the role of microRNAs in ENS development, function, and the onset of gastrointestinal diseases |
| 12 | Holzer and Holzer-Petsche[65] | Studies how anti-calcitonin gene-related peptide migraine therapeutics may cause constipation by antagonizing the motor functions of the intestine | Examines the ENS's involvement in gastrointestinal motility affected by treatments for other conditions |
| 13 | Kimono[66] | Discusses gastrointestinal issues and therapeutic approaches in Gulf War illness | Focuses on the complex interplay between the ENS and the broader neurological and immune systems in disease contexts |
| 14 | Linan-Rico et al[67] | Investigates the role of enteric glial cells in inflammation and their potential therapeutic implications for GI diseases | Highlights the critical role of ENS glial cells in inflammation and their therapeutic potential in gastrointestinal disorders |
| 15 | Mace et al[68] | Provides insights into the pharmacology and physiology of gastrointestinal enteroendocrine cells | Explores the interaction between ENS and enteroendocrine cells in regulating gut physiology and responses |
| 16 | Morales-Soto and Gulbransen[69] | Discusses how enteric glia significantly contributes to abdominal pain in gastrointestinal discomfort | Sheds light on the role of ENS glial cells in mediating abdominal pain and their emerging role in therapeutic strategies |
| 17 | O'Mahony et al[70] | Examines the connection between early-life stress and the development of irritable bowel syndrome and psychiatric comorbidities | Investigates the role of the ENS in the brain-gut axis, highlighting its importance in IBS and related conditions |
| 18 | Tait and Sayuk[71] | Studies the brain-gut-microbiota axis in functional gastrointestinal illnesses and potential therapeutic interventions | Explores the role of the ENS as a mediator between the brain, gut, and microbiota in functional gastrointestinal disorders |
| 19 | Weber[72] | Discusses new treatment options for irritable bowel syndrome with predominant diarrhea | Focuses on therapeutic targets within the ENS to treat IBS with diarrhea |
| 20 | Zhang et al[73] | Explores how EphrinB2/ephB2 activation facilitates colonic synaptic potentiation and contributes to long-term visceral hypersensitivity in IBS | Focuses on the role of synaptic plasticity in the ENS, contributing to visceral hypersensitivity in IBS |
- Citation: Agrawal H, Agarwal N, Gupta N. Enteric nervous system as a therapeutic target in gastrointestinal disorders. World J Gastrointest Pharmacol Ther 2025; 16(4): 110843
- URL: https://www.wjgnet.com/2150-5349/full/v16/i4/110843.htm
- DOI: https://dx.doi.org/10.4292/wjgpt.v16.i4.110843